Your browser doesn't support javascript.
loading
Definitions, outcomes, and management of hyperprogression in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors.
Abbar, B; De Castelbajac, V; Gougis, P; Assoun, S; Pluvy, J; Tesmoingt, C; Théou-Anton, N; Cazes, A; Namour, C; Khalil, A; Gounant, V; Besse, B; Zalcman, G; Brosseau, S.
Affiliation
  • Abbar B; Department of Thoracic Oncology, Bichat-Claude Bernard Hospital, AP-HP, Sorbonne University, Paris, France.
  • De Castelbajac V; Breast Disease Center, Saint Louis Hospital, AP-HP, Université de Paris, Paris, France.
  • Gougis P; Department of Pharmacology, Department of Medical Oncology, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University, INSERM, CIC-1901 Paris-Est, CLIP(2)Galilée, Paris, France.
  • Assoun S; Department of Thoracic Oncology, CIC 1425 INSERM, Bichat-Claude Bernard Hospital, AP-HP, Université de Paris, Paris, France.
  • Pluvy J; Department of Thoracic Oncology, CIC 1425 INSERM, Bichat-Claude Bernard Hospital, AP-HP, Université de Paris, Paris, France.
  • Tesmoingt C; Department of Clinical Pharmacy, Bichat-Claude Bernard Hospital, AP-HP, Paris, France.
  • Théou-Anton N; Department of Genetics, Bichat-Claude Bernard Hospital, AP-HP, Paris, France.
  • Cazes A; Department of Pathology, Bichat-Claude Bernard Hospital, Université de Paris, AP-HP, Paris, France.
  • Namour C; Department of Thoracic Oncology, CIC 1425 INSERM, Bichat-Claude Bernard Hospital, AP-HP, Université de Paris, Paris, France.
  • Khalil A; Department of Radiology, University Hospital Bichat-Claude Bernard, AP-HP, Paris, France.
  • Gounant V; Department of Thoracic Oncology, CIC 1425 INSERM, Bichat-Claude Bernard Hospital, AP-HP, Université de Paris, Paris, France.
  • Besse B; Department of Cancer Medicine, Institut Gustave Roussy, Saclay University Villejuif, France.
  • Zalcman G; Department of Thoracic Oncology, CIC 1425 INSERM, Bichat-Claude Bernard Hospital, AP-HP, Université de Paris, Paris, France. Electronic address: gerard.zalcman@aphp.fr.
  • Brosseau S; Department of Thoracic Oncology, CIC 1425 INSERM, Bichat-Claude Bernard Hospital, AP-HP, Université de Paris, Paris, France.
Lung Cancer ; 152: 109-118, 2021 02.
Article in En | MEDLINE | ID: mdl-33385736
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: France Country of publication: Ireland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: France Country of publication: Ireland